beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->3)-alpha-D-GalpNAc

Term ID

CHEBI:71054

Synonyms

alpha-D-galactopyranose, O-beta-D-galactopyranosyl-(1->4)-O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1->3)-2-(acetylamino)-2-deoxy-
beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-alpha-D-GalNAc
beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-2-acetamido-2-deoxy-alpha-D-galactopyranose
beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-N-acetyl-alpha-D-galactosamine
Galb1-4GlcNAcb1-3GalNAca
Galbeta1-4GlcNAcalpha1-3GalNAcbeta
O-beta-D-galactopyranosyl-(1->4)-O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1->3)-2-(acetylamino)-2-deoxy-alpha-D-galactopyranose

Definition

β-D-Galp-(1→4)-β-D-GlcpNAc-(1→3)-D-GalpNAc with α-configuration at the anomeric centre of the reducing-end GalNAc residue.

References

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->3)-alpha-D-GalpNAc

Phenotype where environments contain beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->3)-alpha-D-GalpNAc

Phenotype modified by environments containing beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->3)-alpha-D-GalpNAc

Phenotype affecting beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->3)-alpha-D-GalpNAc

Human Disease Model